U.S. Physical Therapy, Inc. (USPH) Plans $0.20 Quarterly Dividend
U.S. Physical Therapy, Inc. (NYSE:USPH) declared a quarterly dividend on Tuesday, October 31st, NASDAQ reports. Investors of record on Friday, November 17th will be given a dividend of 0.20 per share on Friday, December 8th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date of this dividend is Thursday, November 16th.
U.S. Physical Therapy has increased its dividend by an average of 19.3% annually over the last three years and has increased its dividend every year for the last 6 years. U.S. Physical Therapy has a dividend payout ratio of 38.5% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect U.S. Physical Therapy to earn $2.41 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 33.2%.
U.S. Physical Therapy (NYSE:USPH) traded down $0.15 during midday trading on Friday, hitting $68.20. The company had a trading volume of 36,094 shares, compared to its average volume of 67,106. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.26 and a current ratio of 2.04. U.S. Physical Therapy has a 52-week low of $56.50 and a 52-week high of $78.00. The stock has a market capitalization of $859.29, a price-to-earnings ratio of 32.99, a P/E/G ratio of 2.93 and a beta of 1.07.
U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, November 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.52 by ($0.04). U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. The company had revenue of $103.03 million for the quarter, compared to analysts’ expectations of $102.69 million. equities analysts forecast that U.S. Physical Therapy will post 2.08 EPS for the current year.
In other U.S. Physical Therapy news, COO Glenn Mcdowell sold 2,598 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $57.00, for a total value of $148,086.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Lawrance W. Mcafee sold 800 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $69.21, for a total value of $55,368.00. The disclosure for this sale can be found here. Insiders sold a total of 26,266 shares of company stock worth $1,703,306 in the last ninety days. 3.10% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: This piece of content was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.watchlistnews.com/u-s-physical-therapy-inc-usph-plans-0-20-quarterly-dividend/1695523.html.
A number of equities analysts recently issued reports on the company. Barrington Research lowered U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a report on Friday, November 3rd. Cantor Fitzgerald reissued a “buy” rating and set a $74.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 2nd. BidaskClub raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, October 25th. Zacks Investment Research lowered U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Saturday, October 7th. Finally, Jefferies Group LLC set a $65.00 price objective on U.S. Physical Therapy and gave the company a “hold” rating in a report on Friday, August 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $69.00.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.